Search

Search Results
Results 1061 - 1070 of 1084 for Acute kidney failure
  • Drug - 5 Jun 2024
    Consumer Medicine Information (CMI) about Prograf and Advagraf XL intended for persons living in Australia.
  • Drug - 29 May 2024
    Consumer Medicine Information (CMI) about Spiriva Respimat (with dose indicator) intended for persons living in Australia.
  • Drug - 23 Apr 2024
    Consumer Medicine Information (CMI) about Iclusig intended for persons living in Australia.
  • Drug - 4 Apr 2024
    Consumer Medicine Information (CMI) about Reyataz intended for persons living in Australia.
  • Drug - 21 Mar 2024
    Consumer Medicine Information (CMI) about Afinitor intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Erbitux intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Vttack intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Olamlo HCT (Olmesartan medoxomil, amlodipine and hydrochlorothiazide) intended for persons living in Australia.
  • Health - 21 Jul 2023
    The vast majority of pollution-related deaths are linked to fine particles less than 2.5 millionths of a metre (known as PM2.5).
  • Health - 19 Jun 2023
    Diagnosis of eating disorders is a process that begins with acceptance of its presence. Often the patient needs to be convinced of its presence as there is severe denial and resistance to the problem.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.